Pathology Analysis & Statistics, October 2014 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Cancer, Breast Cancer, Leukemia, more »

871-920 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

Dynavax Technologies Corporation (Symbol:DVAX) SWOT Analysis, Strategy, Revenues and Profits

Dynavax Technologies Corporation (Symbol:DVAX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Lipidviro Tech, Inc. (Symbol:LPVO) SWOT Analysis, Strategy, Revenues and Profits

Lipidviro Tech, Inc. (Symbol:LPVO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Lovelace Respiratory Research Institute SWOT Analysis, Strategy, Revenues and Profits

Lovelace Respiratory Research Institute SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Ludwig Institute For Cancer Research Ltd SWOT Analysis, Strategy, Revenues and Profits

Ludwig Institute For Cancer Research Ltd SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
MacKay Life Sciences, Inc. (Symbol:BZEC) SWOT Analysis, Strategy, Revenues and Profits

MacKay Life Sciences, Inc. (Symbol:BZEC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Microbix Biosystems Inc. (Symbol:MBX) SWOT Analysis, Strategy, Revenues and Profits

Microbix Biosystems Inc. (Symbol:MBX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada
Micrus Endovascular Corporation (Symbol:MEND) SWOT Analysis, Strategy, Revenues and Profits

Micrus Endovascular Corporation (Symbol:MEND) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review

Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Medivir AB (Medivir) is a pharmaceutical company. It focuses on the research and development of drugs for the treatment of infectious diseases. The pipeline portfolio of the company includes Xerclea ...

  • Industries : Pathology
Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic SWOT Analysis Review

Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Raptor Pharmaceuticals Corp. (Raptor) is a biopharmaceutical company. It develops and commercializes drugs that help in treating debilitating and fatal diseases. The company's product, Procysbi, ...

  • Industries : Pathology
  • Countries : United States
Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : China
Somnomed Limited (Symbol:SOMDA) SWOT Analysis, Strategy, Revenues and Profits

Somnomed Limited (Symbol:SOMDA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia, United States, Spain, Portugal
STAAR Surgical Company - Strategic SWOT Analysis Review

STAAR Surgical Company - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary STAAR Surgical Company (STAAR) is a medical device company. The company designs, develops, manufactures and markets implantable lenses for the eye and delivery systems. Its products include refractive ...

  • Industries : Pathology
  • Countries : United States
Spinal Restoration, Inc. SWOT Analysis, Strategy, Revenues and Profits

Spinal Restoration, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Strides Arcolab Limited (Strides Arcolab) is a pharmaceutical company. The company specializes in manufacturing soft gelatin capsules. Strides Arcolab serves areas such as pharma generics, branded ...

  • Industries : Pathology
  • Countries : United States, World, Australia, South Africa
Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada
Sunshine Heart Company, Pty. Ltd. (Symbol:SHC) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Heart Company, Pty. Ltd. (Symbol:SHC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
The Jackson Laboratory SWOT Analysis, Strategy, Revenues and Profits

The Jackson Laboratory SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
The Scripps Research Institute SWOT Analysis, Strategy, Revenues and Profits

The Scripps Research Institute SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Theralase Technologies, Inc. (Symbol:TLT) SWOT Analysis, Strategy, Revenues and Profits

Theralase Technologies, Inc. (Symbol:TLT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada, United States
Stentys, S.A (STNT) - Financial and Strategic SWOT Analysis Review

Stentys, S.A (STNT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Stentys, S.A (Stentys) is a medical technology company. The company develops and offers solutions to cardiologists to treat patients with acute myocardial infarction and coronary disease. Its products ...

  • Industries : Pathology
  • Countries : France, Switzerland, Netherlands, Spain, Poland, Italy, Germany, United Arab Emirates
TI Pharma SWOT Analysis, Strategy, Revenues and Profits

TI Pharma SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Netherlands
Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
TOA EIYO LTD. SWOT Analysis, Strategy, Revenues and Profits

TOA EIYO LTD. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Japan
Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : New Zealand, United States
Zealand Pharma A/S (Symbol:ZEAL) SWOT Analysis, Strategy, Revenues and Profits

Zealand Pharma A/S (Symbol:ZEAL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
AtheroNova Inc. (Symbol:AHRO) SWOT Analysis, Strategy, Revenues and Profits

AtheroNova Inc. (Symbol:AHRO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Endocyte, Inc. (Endocyte) is a biopharmaceutical company. The company develops and markets therapies for the treatment of cancer and other inflammatory diseases. Its pipeline products include Vynfinit ...

  • Industries : Pathology
  • Countries : United States
About 31 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US, Weekly Update

  • Communicable Diseases/epidemiology Influenza Weekly Report Arkan...
  • November 2014
    10 pages
  • Influenza  

    Infectious Dise...  

  • United States  

    North America  

View report >

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.